InMode (INMD) Competitors $14.91 -0.49 (-3.18%) As of 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock INMD vs. IRTC, SLNO, PRCT, TMDX, NVST, LIVN, LMAT, ENOV, NVCR, and CNMDShould you be buying InMode stock or one of its competitors? The main competitors of InMode include iRhythm Technologies (IRTC), Soleno Therapeutics (SLNO), PROCEPT BioRobotics (PRCT), TransMedics Group (TMDX), Envista (NVST), LivaNova (LIVN), LeMaitre Vascular (LMAT), Enovis (ENOV), NovoCure (NVCR), and CONMED (CNMD). These companies are all part of the "medical equipment" industry. InMode vs. iRhythm Technologies Soleno Therapeutics PROCEPT BioRobotics TransMedics Group Envista LivaNova LeMaitre Vascular Enovis NovoCure CONMED iRhythm Technologies (NASDAQ:IRTC) and InMode (NASDAQ:INMD) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, community ranking, institutional ownership, valuation, profitability, media sentiment, analyst recommendations, earnings and dividends. Is IRTC or INMD more profitable? InMode has a net margin of 45.91% compared to iRhythm Technologies' net margin of -19.14%. InMode's return on equity of 18.25% beat iRhythm Technologies' return on equity.Company Net Margins Return on Equity Return on Assets iRhythm Technologies-19.14% -118.83% -11.34% InMode 45.91%18.25%16.33% Does the media prefer IRTC or INMD? In the previous week, InMode had 10 more articles in the media than iRhythm Technologies. MarketBeat recorded 16 mentions for InMode and 6 mentions for iRhythm Technologies. iRhythm Technologies' average media sentiment score of 1.05 beat InMode's score of 0.79 indicating that iRhythm Technologies is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment iRhythm Technologies 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive InMode 7 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive Which has preferable earnings and valuation, IRTC or INMD? InMode has lower revenue, but higher earnings than iRhythm Technologies. iRhythm Technologies is trading at a lower price-to-earnings ratio than InMode, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioiRhythm Technologies$591.84M5.30-$123.41M-$3.64-27.43InMode$394.82M2.63$181.27M$2.356.34 Do analysts rate IRTC or INMD? iRhythm Technologies currently has a consensus target price of $119.73, suggesting a potential upside of 19.92%. InMode has a consensus target price of $21.25, suggesting a potential upside of 42.52%. Given InMode's higher probable upside, analysts clearly believe InMode is more favorable than iRhythm Technologies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score iRhythm Technologies 0 Sell rating(s) 2 Hold rating(s) 9 Buy rating(s) 0 Strong Buy rating(s) 2.82InMode 0 Sell rating(s) 3 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.40 Which has more risk & volatility, IRTC or INMD? iRhythm Technologies has a beta of 1.45, indicating that its stock price is 45% more volatile than the S&P 500. Comparatively, InMode has a beta of 1.96, indicating that its stock price is 96% more volatile than the S&P 500. Does the MarketBeat Community believe in IRTC or INMD? iRhythm Technologies received 247 more outperform votes than InMode when rated by MarketBeat users. However, 72.97% of users gave InMode an outperform vote while only 66.07% of users gave iRhythm Technologies an outperform vote. CompanyUnderperformOutperformiRhythm TechnologiesOutperform Votes40966.07% Underperform Votes21033.93% InModeOutperform Votes16272.97% Underperform Votes6027.03% Do insiders & institutionals believe in IRTC or INMD? 68.0% of InMode shares are owned by institutional investors. 0.7% of iRhythm Technologies shares are owned by company insiders. Comparatively, 6.9% of InMode shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. SummaryInMode beats iRhythm Technologies on 12 of the 18 factors compared between the two stocks. Remove Ads Get InMode News Delivered to You Automatically Sign up to receive the latest news and ratings for INMD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart INMD vs. The Competition Export to ExcelMetricInModeElectromedical equipment IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.04B$3.08B$5.27B$7.29BDividend YieldN/A1.80%5.11%4.32%P/E Ratio6.3414.5521.6417.60Price / Sales2.6343.42370.8091.75Price / Cash10.4044.0938.1534.64Price / Book1.473.256.353.91Net Income$181.27M$94.03M$3.20B$247.45M7 Day Performance-3.56%-4.22%1.34%0.02%1 Month Performance-18.57%-10.14%-9.78%-7.53%1 Year Performance-15.38%-22.83%9.22%-0.82% InMode Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)INMDInMode2.235 of 5 stars$14.91-3.2%$21.25+42.5%-12.9%$1.04B$394.82M6.34480Analyst ForecastNews CoverageIRTCiRhythm Technologies0.9182 of 5 stars$103.20+1.1%$119.73+16.0%-8.0%$3.24B$591.84M-28.351,790Positive NewsSLNOSoleno Therapeutics4.7799 of 5 stars$70.00+4.1%$99.63+42.3%+82.4%$3.21BN/A-21.0830Analyst ForecastPositive NewsPRCTPROCEPT BioRobotics2.3921 of 5 stars$53.76+3.2%$91.43+70.1%+4.6%$2.95B$224.50M-27.57430Positive NewsTMDXTransMedics Group2.751 of 5 stars$86.84+7.8%$122.70+41.3%-5.1%$2.92B$441.54M92.38210NVSTEnvista4.3739 of 5 stars$15.63+1.1%$20.18+29.1%-21.0%$2.69B$2.51B-2.4112,700Analyst ForecastAnalyst RevisionNews CoverageLIVNLivaNova3.5606 of 5 stars$35.46+4.4%$61.17+72.5%-34.8%$1.93B$1.25B84.432,900Positive NewsLMATLeMaitre Vascular3.0966 of 5 stars$83.78+1.2%$95.25+13.7%+31.3%$1.89B$219.86M45.78490Positive NewsENOVEnovis2.2083 of 5 stars$32.28+0.8%$58.50+81.2%-44.7%$1.84B$2.11B-14.746,800NVCRNovoCure3.3424 of 5 stars$16.55+0.3%$34.50+108.5%+29.4%$1.82B$605.22M-11.821,320Analyst ForecastNews CoverageGap UpCNMDCONMED4.6474 of 5 stars$50.91-1.6%$77.20+51.6%-35.5%$1.57B$1.31B12.014,100 Remove Ads Related Companies and Tools Related Companies IRTC Alternatives SLNO Alternatives PRCT Alternatives TMDX Alternatives NVST Alternatives LIVN Alternatives LMAT Alternatives ENOV Alternatives NVCR Alternatives CNMD Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:INMD) was last updated on 4/16/2025 by MarketBeat.com Staff From Our PartnersTrump Makes Major Crypto AnnouncementTrump Ends the “War on Crypto” I expect it to pump the market, which is why I'm recommending ONE coin to al...Crypto 101 Media | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredDOGE tax surpriseElon Musk's DOGE agents have some very strange plans for the IRS... Recently, it emerged that our tax auth...Altimetry | SponsoredIs it CRAZY to still want reliable profits, despite this market?Larry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...Brownstone Research | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredFirst look: The $3,500 iPhoneDid you hear that just before Trump's tariffs took effect, Apple sent five cargo planes packed with MacBooks a...Stansberry Research | SponsoredMarkets in Chaos? Here’s What to Do.Wall Street's on edge with tariffs. And volatility? It's not slowing down. You've seen the headlines… Bu...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding InMode Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share InMode With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.